MYUNGIN PHARM.CO., LTD

317450 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩44,100.00
+0.57%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.06.
  • Comfortable interest cover: operating profit covers interest about 104 times.
  • Return on equity is moderate at 10.3%.
  • Return on capital employed is moderate at 11.6%.
  • Net profit margin is strong at 28.4%.
  • Current assets comfortably cover current liabilities (current ratio 13.93).
  • Pays a dividend (yield about 2.08%).

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
2.56

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the market-value term.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩6,439억
Current Price₩ 44,100.00
High / Low₩ 118,700.00 / 39,100.00
Stock P/E7.91
Book Value₩ 54,409.46
Dividend Yield2.08%
ROCE11.63%
ROE10.25%
Debt to Equity0.06
Current Ratio13.93
EPS₩ 5,577.75
PAT Margin28.35%
ICR104.03
Educational data only. Not a recommendation to buy, sell or hold any security.